カルナバイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/29 | 1,560 | 1,617 | 1,550 | 1,600 | +28 | +1.8% | 195,900 |
2020/05/28 | 1,560 | 1,572 | 1,538 | 1,572 | -4 | -0.3% | 165,900 |
2020/05/27 | 1,535 | 1,578 | 1,520 | 1,576 | +23 | +1.5% | 186,900 |
2020/05/26 | 1,540 | 1,573 | 1,507 | 1,553 | +18 | +1.2% | 188,300 |
2020/05/25 | 1,556 | 1,569 | 1,516 | 1,535 | -18 | -1.2% | 176,200 |
2020/05/22 | 1,545 | 1,559 | 1,524 | 1,553 | -4 | -0.3% | 153,900 |
2020/05/21 | 1,595 | 1,596 | 1,538 | 1,557 | -39 | -2.4% | 277,700 |
2020/05/20 | 1,555 | 1,600 | 1,555 | 1,596 | +29 | +1.9% | 198,600 |
2020/05/19 | 1,539 | 1,579 | 1,508 | 1,567 | +57 | +3.8% | 277,800 |
2020/05/18 | 1,489 | 1,520 | 1,451 | 1,510 | +23 | +1.5% | 199,200 |
2020/05/15 | 1,497 | 1,531 | 1,433 | 1,487 | -9 | -0.6% | 237,400 |
2020/05/14 | 1,539 | 1,550 | 1,484 | 1,496 | -47 | -3% | 251,500 |
2020/05/13 | 1,479 | 1,633 | 1,479 | 1,543 | +24 | +1.6% | 685,000 |
2020/05/12 | 1,474 | 1,541 | 1,455 | 1,519 | +67 | +4.6% | 230,400 |
2020/05/11 | 1,470 | 1,483 | 1,442 | 1,452 | -15 | -1% | 162,800 |
2020/05/08 | 1,605 | 1,608 | 1,456 | 1,467 | -67 | -4.4% | 294,400 |
2020/05/07 | 1,467 | 1,540 | 1,467 | 1,534 | +75 | +5.1% | 285,800 |
2020/05/01 | 1,447 | 1,472 | 1,412 | 1,459 | -15 | -1% | 172,200 |
2020/04/30 | 1,468 | 1,522 | 1,447 | 1,474 | +17 | +1.2% | 261,700 |
2020/04/28 | 1,433 | 1,480 | 1,413 | 1,457 | +26 | +1.8% | 157,200 |
2020/04/27 | 1,420 | 1,448 | 1,411 | 1,431 | +13 | +0.9% | 113,700 |
2020/04/24 | 1,399 | 1,455 | 1,385 | 1,418 | +19 | +1.4% | 164,400 |
2020/04/23 | 1,424 | 1,426 | 1,377 | 1,399 | -1 | -0.1% | 105,000 |
2020/04/22 | 1,385 | 1,449 | 1,376 | 1,400 | -12 | -0.8% | 144,100 |
2020/04/21 | 1,501 | 1,501 | 1,385 | 1,412 | -79 | -5.3% | 273,200 |
2020/04/20 | 1,419 | 1,540 | 1,397 | 1,491 | +97 | +7% | 472,700 |
2020/04/17 | 1,440 | 1,440 | 1,378 | 1,394 | -1 | -0.1% | 164,100 |
2020/04/16 | 1,342 | 1,413 | 1,342 | 1,395 | +24 | +1.8% | 166,600 |
2020/04/15 | 1,360 | 1,385 | 1,333 | 1,371 | -5 | -0.4% | 89,000 |
2020/04/14 | 1,311 | 1,383 | 1,310 | 1,376 | +65 | +5% | 183,100 |
2020/04/13 | 1,289 | 1,329 | 1,255 | 1,311 | +21 | +1.6% | 146,300 |
2020/04/10 | 1,301 | 1,324 | 1,251 | 1,290 | -35 | -2.6% | 161,400 |
2020/04/09 | 1,280 | 1,329 | 1,274 | 1,325 | +57 | +4.5% | 149,300 |
2020/04/08 | 1,231 | 1,271 | 1,187 | 1,268 | +37 | +3% | 152,700 |
2020/04/07 | 1,254 | 1,263 | 1,190 | 1,231 | -4 | -0.3% | 206,000 |
2020/04/06 | 1,140 | 1,238 | 1,129 | 1,235 | +72 | +6.2% | 180,900 |
2020/04/03 | 1,221 | 1,242 | 1,152 | 1,163 | -58 | -4.8% | 248,500 |
2020/04/02 | 1,270 | 1,283 | 1,215 | 1,221 | -58 | -4.5% | 181,500 |
2020/04/01 | 1,301 | 1,339 | 1,264 | 1,279 | -30 | -2.3% | 140,500 |
2020/03/31 | 1,324 | 1,382 | 1,302 | 1,309 | +11 | +0.8% | 214,200 |
2020/03/30 | 1,271 | 1,328 | 1,268 | 1,298 | -33 | -2.5% | 162,600 |
2020/03/27 | 1,320 | 1,360 | 1,291 | 1,331 | +66 | +5.2% | 283,700 |
2020/03/26 | 1,226 | 1,342 | 1,210 | 1,265 | -10 | -0.8% | 358,400 |
2020/03/25 | 1,225 | 1,294 | 1,179 | 1,275 | +110 | +9.4% | 508,800 |
2020/03/24 | 1,130 | 1,202 | 1,127 | 1,165 | +65 | +5.9% | 389,700 |
2020/03/23 | 1,107 | 1,138 | 1,070 | 1,100 | -67 | -5.7% | 340,900 |
2020/03/19 | 1,296 | 1,305 | 1,081 | 1,167 | -69 | -5.6% | 756,000 |
2020/03/18 | 1,480 | 1,538 | 1,222 | 1,236 | -73 | -5.6% | 2,888,200 |
2020/03/17 | 1,279 | 1,309 | 1,263 | 1,309 | +300 | +29.7% | 265,000 |
2020/03/16 | 1,040 | 1,123 | 1,000 | 1,009 | -19 | -1.8% | 315,000 |
1101~
1150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
VIS | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 84,500円 | +240.0% | - | 0.00% | - | 2.75倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
市場注目の銘柄
チャート関連のコラム